Search Within

Genitourinary Oncology Service

  1. "2016"
Formats
  1. Meeting Abstract (175)
  2. Journal Article (132)
  3. Book Section (2)
Groups
  1. Department of Medicine (309)
  2. Solid Tumor Oncology Division (309)
  3. GSK Faculty (90)
  4. Human Oncology and Pathogenesis Program (78)
  5. Department of Pathology and Laboratory Medicine (73)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (56)

More Groups

People
  1. Robert Motzer (74)
  2. David Solit (55)
  3. Jonathan Rosenberg (47)
  4. Michael Berger (42)
  5. Dean Bajorin (34)
  6. Howard Scher (34)

More People

Years
  1. 2016 (309)
Publications
  1. Journal of Clinical Oncology (116)
  2. Annals of Oncology (33)
  3. BJU International (13)
  4. Clinical Cancer Research (8)
  5. Journal for ImmunoTherapy of Cancer (8)
  6. European Urology (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (117)
  2. Oxford University Press (35)
  3. Wiley Blackwell (21)
  4. Nature Publishing Group (20)
  5. Elsevier Science, Inc. (17)
  6. American Association for Cancer Research (16)

More Publishers

Results (309)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular and clinical characterization of gliosarcomas
    Meeting Abstract

    Wu, S.; Brennan, C.; Zahir, A.; Berger, M.; Solit, D.; Hyman, D.; Huse, J.; Rosenblum, M.; Omuro, A.
    Neurology (2016)

    Fulltext@MSK | Save
  • Atezolizumab (atezo) as first-line (1L) therapy in cisplatin-ineligible locally advanced/metastatic urothelial carcinoma (mUC): Primary analysis of IMvigor210 cohort 1
    Meeting Abstract

    Balar, A. V.; Galsky, M. D.; Loriot, Y.; Dawson, N. A.; Necchi, A.; Srinivas, S.; Joseph, R. W.; Vaishampayan, U. N.; Sridhar, S. S.; Quinn, D. I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Prevalence of clonal hematopoiesis in patients with advanced cancer
    Meeting Abstract

    Zehir, A.; Coombs, C. C.; Devlin, S.; Kishtagari, A.; Hyman, D. M.; Solit, D. B.; Robson, M. E.; Baselga, J.; Arcila, M. E.; Tallman, M. S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Concurrent genetic alterations identified by next-generation sequencing in pre-treatment metastatic EGFR-mutant lung cancers
    Meeting Abstract

    Yu, H. A.; Jordan, E.; Ni, A.; Feldman, D.; Rodriguez, C.; Kim, H. R.; Kris, M. G.; Solit, D. B.; Berger, M. F.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genome-wide association study (GWAS) of cisplatin-related hearing loss in testicular cancer survivors (TCS) to reveal associated variant in Wolfram syndrome 1 (WFS1) gene
    Meeting Abstract

    Wheeler, H. E.; Frisina, R. D.; Gamazon, E. R.; El Charif, O.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Beard, C.; Fung, C.; Einhorn, L. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Baseline lactate dehydrogenase (LDH) and overall survival (OS) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with everolimus (EVE) versus sunitinib (SUN): Predictive biomarker analysis from the RECORD-3 trial
    Meeting Abstract

    Voss, M. H.; Chen, D.; Marker, M.; Knox, J.; Hsieh, J.; Voi, M.; Motzer, R. J.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic landscape of defective DNA damage response and repair mechanisms (DDR) across cancer types
    Meeting Abstract

    Teo, M.; Zabor, E. C.; Iyer, G.; Bambury, R.; Boyd, M. E.; Rosenberg, J. E.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP)
    Meeting Abstract

    Sweeney, C.; Xie, W.; Regan, M. M.; Nakabayashi, M.; Buyse, M. E.; Clarke, N. W.; Collette, L.; Dignam, J. J.; Fizazi, K.; Habibian, M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Exploring the role of RB and AR in a phase II randomized multicenter trial of abiraterone acetate with or without cabazitaxel in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Slovin, S. F.; Knudsen, K. E.; Carbone, E.; Showunmi, A.; Hullings, M.; Morris, M. J.; Autio, K. A.; Kampel, L. J.; Molina, A. M.; Chen, Y.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Serial next generation sequencing (NGS) of cell free DNA (cfDNA) and clonal evolution of AKT1 E17K mutant tumors: Analyses from patients (pts) enrolled on a phase I basket study of an AKT inhibitor (AZD5363)
    Meeting Abstract

    Smyth, L. M.; Reichel, J. B.; Tang, J.; Patel, J. A. A.; Meng, F.; Selcuklu, S. D.; You, D.; Samoila, A.; Schiavon, G.; Li, B. T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save